Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301.
Kobayashi M, Matsui K, Iwamoto Y, Ebi N, Oizumi S, Takeda K, Sawa T, Shibata K, Saka H, Imamura F, Seki N, Saito H, Goto I, Nakagawa K; West Japan Oncology Group. Kobayashi M, et al. J Thorac Oncol. 2010 Jul;5(7):1075-80. doi: 10.1097/JTO.0b013e3181dd1591. J Thorac Oncol. 2010. PMID: 20479694 Free article. Clinical Trial.
A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer.
Matsui K, Hirashima T, Nitta T, Kobayashi M, Ogata Y, Furukawa M, Kudoh S, Yoshimura N, Mukohara T, Yamauchi S, Shiraishi S, Kamoi H, Negoro S, Takeda K, Nakagawa K, Takada M, Yana T, Fukuoka M. Matsui K, et al. Among authors: kobayashi m. Jpn J Clin Oncol. 2005 Apr;35(4):181-7. doi: 10.1093/jjco/hyi057. Jpn J Clin Oncol. 2005. PMID: 15845566 Clinical Trial.
Preliminary experience with a modified premedication protocol that included intravenous diphenhydramine and calcium bromide for the prophylaxis of paclitaxel-related hypersensitivity reactions.
Sasada S, Hirashima T, Nakamura Y, Takimoto T, Furukawa M, Kobayashi M, Nitta T, Matsui K, Kawase I. Sasada S, et al. Among authors: kobayashi m. Int J Clin Oncol. 2007 Aug;12(4):274-8. doi: 10.1007/s10147-007-0675-9. Epub 2007 Aug 20. Int J Clin Oncol. 2007. PMID: 17701006
A phase I study of topotecan plus carboplatin for relapsed SCLC: WJTOG trial.
Kurata T, Kashii T, Takeda K, Seki N, Tsuboi M, Kobayashi M, Satoh T, Nakagawa K, Fukuoka M. Kurata T, et al. Among authors: kobayashi m. J Thorac Oncol. 2009 May;4(5):644-8. doi: 10.1097/JTO.0b013e31819f978a. J Thorac Oncol. 2009. PMID: 19325498 Free article. Clinical Trial.
Prognosis of small-cell lung cancer since the introduction of amrubicin.
Suzuki H, Hirashima T, Kobayashi M, Sasada S, Okamoto N, Tamiya M, Matsuura Y, Morishita N, Uehara N, Matsui K, Kawase I. Suzuki H, et al. Among authors: kobayashi m. Med Oncol. 2011 Dec;28(4):1430-5. doi: 10.1007/s12032-010-9623-z. Epub 2010 Jul 15. Med Oncol. 2011. PMID: 20632217
12,154 results
You have reached the last available page of results. Please see the User Guide for more information.